Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B MACH

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1983
Isolation of cDNA clones for the p33 invariant chain associated with HLA-DR antigensE O Long, M Strubin, C T Wake, et al.
International Journal of Cancer|February 21, 2003
Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous systemMary Ann C Sabino, Nancy M Luger, David B Mach, et al.
Clinical Immunology and Immunopathology|January 1, 1989
Combined immunodeficiency with abnormal expression of MHC class II genesC Griscelli, B Lisowska-Grospierre, F Le Deist, et al.
Cell|June 17, 1988
Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-XW Reith, S Satola, C H Sanchez, et al.
Human Immunology|August 1, 1994
An HLA-DRB alpha-helix motif shared by DR11 and DR8 alleles is implicated in the pluriallelic restriction of peptide-specific T-cell linesE Martínez-Soria, V Steimle, C Burkhardt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1997
Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITAM B Bradley, J M Fernandez, G Ungers, et al.
Human Immunology|December 1, 1987
HLA-DR alpha, -DX alpha, and DR beta III gene association studies in DR3 individualsJ Gorski, M J Niven, J A Sachs, et al.
Tissue Antigens|September 1, 1993
Functional dissection of the serological DR LYGUE and genotypic DRB1*1303 specificities using a tetanus toxin-specific T-cell cloneE Martínez-Soria, J M Tiercy, P Beffy, et al.
Human Mutation|January 1, 1997
Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiencyJ Villard, W Reith, E Barras, et al.
Nature Genetics|November 7, 1998
A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patientsK Masternak, E Barras, M Zufferey, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1983
Isolation of cDNA clones for the p33 invariant chain associated with HLA-DR antigensE O Long, M Strubin, C T Wake, et al.
International Journal of Cancer|February 21, 2003
Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous systemMary Ann C Sabino, Nancy M Luger, David B Mach, et al.
Clinical Immunology and Immunopathology|January 1, 1989
Combined immunodeficiency with abnormal expression of MHC class II genesC Griscelli, B Lisowska-Grospierre, F Le Deist, et al.
Cell|June 17, 1988
Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-XW Reith, S Satola, C H Sanchez, et al.
Human Immunology|August 1, 1994
An HLA-DRB alpha-helix motif shared by DR11 and DR8 alleles is implicated in the pluriallelic restriction of peptide-specific T-cell linesE Martínez-Soria, V Steimle, C Burkhardt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1997
Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITAM B Bradley, J M Fernandez, G Ungers, et al.
Human Immunology|December 1, 1987
HLA-DR alpha, -DX alpha, and DR beta III gene association studies in DR3 individualsJ Gorski, M J Niven, J A Sachs, et al.
Tissue Antigens|September 1, 1993
Functional dissection of the serological DR LYGUE and genotypic DRB1*1303 specificities using a tetanus toxin-specific T-cell cloneE Martínez-Soria, J M Tiercy, P Beffy, et al.
Human Mutation|January 1, 1997
Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiencyJ Villard, W Reith, E Barras, et al.
Nature Genetics|November 7, 1998
A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patientsK Masternak, E Barras, M Zufferey, et al.
Pageof 17